A Case of Therapy-Related Acute Myeloid Leukemia Following 5-Fluorouracil Chemotherapy
Hye Jeong Park, Jung-Hye Choi, Kyeong A Lee, Hyun Cheol Kim, Young-Soo Nam, Young-Ha Oh, Woong-Soo Lee
Korean J Intern Med. 2012;27(1):115-117. Published online 2012 Feb 28 DOI: https://doi.org/10.3904/kjim.2012.27.1.115
Citations to this article as recorded by 
Mixed phenotype acute leukaemia with monosomy 7 and BCR-ABL1 translocation following antimetabolite therapy for intrahepatic cholangiocarcinoma
Debadrita Ray, Shano Naseem, Sreejesh Sreedharanunni, Navneet Sharma
Journal of Hematopathology.2022; 15(1): 41. CrossRef
Myeloid malignancies after treatment for solid tumours
Guru Subramanian Guru Murthy, Sameem Abedin
Best Practice & Research Clinical Haematology.2019; 32(1): 40. CrossRef
Establishment of cell line with NK/NKT phenotype from myeloid NK cell acute leukemia
A. Darji, N. Desai, R. Modi, B. Khamar, S. Rajkumar
Leukemia Research.2017; 61: 77. CrossRef
Dietary polyphenols influence antimetabolite agents: methotrexate, 6-mercaptopurine and 5-fluorouracil in leukemia cell lines
Amani Mahbub, Christine Le Maitre, Sarah Haywood-Small, Neil Cross, Nicola Jordan-Mahy
Oncotarget.2017; 8(62): 104877. CrossRef
Therapy‑associated myelodysplastic syndrome with monosomy 7 arising in a Muir‑Torre Syndrome patient carrying SETBP1 mutation
David Ullman, Erin Baumgartner, Nicholas Wnukowski, Gabe Koenig, Fady Mikhail, Peter Pavlidakey, Deniz Peker
Molecular and Clinical Oncology.2017;[Epub] CrossRef